Vital Signs - NIH Stimulus Funding: How to Secure a Piece of the Pie

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on April 20, 2009, provides a strategic overview of ways to secure stimulus package funding for drug discovery technologies. Additionally, a company spotlight is provided for Cellecta, Inc., a provider of genome-wide high throughput screening technologies and services. Reimbursement and regulatory news from the FDA is also provided for the week of April 6, 2009.

Table of Contents

Vital Signs - NIH Stimulus Funding: How to Secure a Piece of the PieVital Signs: 20 April 2009This week's issue:




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.